Geron (GERN) News Today

$1.92

+0.01 (+0.26%)

(As of 10:57 AM ET)

Today's Range: $1.85
▼
$1.92
50-Day Range: $1.74
▼
$2.19
52-Week Range: $1.68
▼
$3.84

Volume: 593,112 shs
Average Volume: 6.58 million shs
Market Capitalization: $1.04 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.75

Source

Source	Headline
	Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors finance.yahoo.com - November 28 at 8:39 AM
	Geron (GERN) Stock Surges After FDA Removes Full Clinical Hold on Imetelstat Application thestreet.com - November 21 at 8:55 PM
	Geron to Participate at Upcoming Investor Conferences in November finance.yahoo.com - November 7 at 8:02 PM
	Geron’s Growth Prospects: Expanding Commercial Team, Imetelstat Development, and Financial Stability markets.businessinsider.com - November 3 at 10:30 AM
	Geron Corporation (NASDAQ:GERN) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 3 at 10:30 AM
	Geron (GERN) Q3 2023 Earnings Call Transcript fool.com - November 2 at 5:09 PM
	Geron Corporation 2023 Q3 - Results - Earnings Call Presentation seekingalpha.com - November 2 at 1:07 PM
	Geron Corporation Q3 Loss beats estimates markets.businessinsider.com - November 2 at 1:01 PM
	Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results finance.yahoo.com - November 2 at 1:01 PM
	Geron IMerge Phase 3 Presentations at Upcoming ASH Annual Meeting Reinforce Significant Durability and Breadth of Effect of Imetelstat in Lower Risk MDS finance.yahoo.com - November 2 at 1:01 PM
	Geron Corp (GERN) Reports Q3 2023 Financial Results and Business Highlights finance.yahoo.com - November 2 at 1:01 PM
	4GERN : Geron Earnings Preview benzinga.com - November 1 at 3:32 PM
	Techne (TECH) Q1 Earnings and Revenues Miss Estimates finance.yahoo.com - October 31 at 1:02 PM
	Geron to Announce Third Quarter 2023 Financial Results on November 2, 2023 finance.yahoo.com - October 26 at 6:35 PM
	Geron Corporation Stock: Another Buying Opportunity seekingalpha.com - October 23 at 4:07 PM
	Rhumbline Advisers Has $2.27 Million Stake in Geron Co. (NASDAQ:GERN) marketbeat.com - September 29 at 5:50 PM
	Geron Reports EMA Validation Of Marketing Authorization Application For Imetelstat markets.businessinsider.com - September 29 at 10:14 AM
	Geron Announces EMA Validation of Marketing Authorization Application for Imetelstat for the Treatment of Lower Risk MDS finance.yahoo.com - September 29 at 10:14 AM
	Goldman Sachs Upgrades Geron (GERN) msn.com - September 13 at 12:31 AM
	Geron Corporation: The FDA, Catalysts And New Competition From Old Drugs msn.com - September 12 at 6:51 PM
	Fairmount Funds Management LLC Invests $15.42 Million in Geron Co. (NASDAQ:GERN) marketbeat.com - September 12 at 12:39 PM
	Geron Taps Michelle Robertson to Succeed Olivia Bloom as Finance Chief marketwatch.com - September 11 at 9:42 PM
	Geron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time ... businesswire.com - September 11 at 9:42 PM
	Geron announces retirement of CFO Olivia Bloom; appoints Michelle Robertson as new CFO msn.com - September 11 at 9:42 PM
	Geron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time Chief Financial Officer finance.yahoo.com - September 11 at 9:42 PM
	Geron Announces Data Presentations from IMerge Phase 3 Evaluating Imetelstat in Lower Risk MDS at Society of Hematologic Oncology Annual Meeting finance.yahoo.com - September 7 at 4:23 PM
	Geron to Participate in the Baird 2023 Global Healthcare Conference finance.yahoo.com - September 5 at 6:31 PM
	Citigroup Inc. Grows Stock Holdings in Geron Co. (NASDAQ:GERN) marketbeat.com - September 5 at 4:52 AM
	Private Advisor Group LLC Makes New Investment in Geron Co. (NASDAQ:GERN) marketbeat.com - September 4 at 5:32 AM
	Wedbush adds Geron to Best Ideas List, joining Ascendis, MoonLake msn.com - September 1 at 5:49 PM
	Short Interest in Geron Co. (NASDAQ:GERN) Rises By 5.0% marketbeat.com - September 1 at 5:46 PM
	Geron (GERN) Gets a Buy from Robert W. Baird markets.businessinsider.com - September 1 at 3:09 AM
	Wedbush Keeps Their Buy Rating on Geron (GERN) markets.businessinsider.com - August 30 at 2:38 AM
	FY2023 EPS Estimates for Geron Co. Increased by Analyst (NASDAQ:GERN) marketbeat.com - August 25 at 6:25 AM
	FDA's Twist In Geron's Telomerase Tale (Rating Downgrade) seekingalpha.com - August 23 at 1:00 PM
	Mirae Asset Global Investments Co. Ltd. Acquires Shares of 80,666 Geron Co. (NASDAQ:GERN) marketbeat.com - August 23 at 4:24 AM
	Geron blood cancer therapy accepted for FDA standard review seekingalpha.com - August 22 at 3:30 PM
	Geron: FDA Assigns PDUFA Action Date For NDA For Imetelstat markets.businessinsider.com - August 22 at 9:50 AM
	Geron Announces PDUFA Date for Imetelstat NDA in Lower Risk MDS finance.yahoo.com - August 22 at 9:50 AM
	FDA Accepts Geron's NDA For Imetelstat For Treatment Of Lower Risk Myelodysplastic Syndromes markets.businessinsider.com - August 21 at 6:49 PM
	Geron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS finance.yahoo.com - August 21 at 6:49 PM
	Robert W. Baird Remains a Buy on Geron (GERN) markets.businessinsider.com - August 8 at 8:36 AM
	FY2026 EPS Estimates for Geron Co. Cut by Analyst (NASDAQ:GERN) marketbeat.com - August 7 at 8:28 AM
	Geron Corporation (GERN) Stock Historical Prices & Data - Yahoo Finance finance.yahoo.com - August 4 at 12:42 PM
	Goldman Sachs Sticks to Their Hold Rating for Geron (GERN) markets.businessinsider.com - August 4 at 12:42 PM
	Geron (NASDAQ:GERN) Earns Buy Rating from Needham & Company LLC marketbeat.com - August 4 at 11:25 AM
	Geron (GERN) Q2 2023 Earnings Call Transcript finance.yahoo.com - August 4 at 2:29 AM
	Geron: Q2 Earnings Snapshot washingtonpost.com - August 3 at 8:25 PM
	Geron Corporation Q2 Loss increases, misses estimates markets.businessinsider.com - August 3 at 8:25 PM
	Geron Corporation Reports Business Highlights and Second Quarter 2023 Financial Results finance.yahoo.com - August 3 at 8:25 PM

Get Geron News Delivered to You Automatically

GERN Media Mentions By Week

GERN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GERN
News Sentiment
▼
0.94

0.82
▲
Average
Medical
News Sentiment

GERN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GERN Articles
This Week
▼
2

2
▲
GERN Articles
Average Week

Get Geron News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:GERN) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Geron (GERN) News Today

GERN Media Mentions By Week

GERN Media Sentiment

GERN News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info